مصطلحات الفهرس: observational study, oncological parameters, overall response rate, overall survival, primary central nervous system lymphoma/dt [Drug Therapy], primary central nervous system lymphoma/rt [Radiotherapy], priority journal, progression free survival, retrospective study, salvage therapy, survival analysis, survival rate, treatment outcome, treatment refusal, treatment response, whole brain radiotherapy, corticosteroid, cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/to [Drug Toxicity], cytarabine/pv [Special Situation for Pharmacovigilance], cytarabine/tm [Unexpected Outcome of Drug Treatment], methotrexate/ae [Adverse Drug Reaction], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], methotrexate/to [Drug Toxicity], methotrexate/tl [Intrathecal Drug Administration], methotrexate/pv [Special Situation for Pharmacovigilance], methotrexate/tm [Unexpected Outcome of Drug Treatment], procarbazine/ae [Adverse Drug Reaction], procarbazine/cb [Drug Combination], procarbazine/dt [Drug Therapy], procarbazine/to [Drug Toxicity], procarbazine/pv [Special Situation for Pharmacovigilance], procarbazine/tm [Unexpected Outcome of Drug Treatment], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], rituximab/to [Drug Toxicity], rituximab/pv [Special Situation for Pharmacovigilance], rituximab/tm [Unexpected Outcome of Drug Treatment], vincristine/ae [Adverse Drug Reaction], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], vincristine/to [Drug Toxicity], vincristine/pv [Special Situation for Pharmacovigilance], vincristine/tm [Unexpected Outcome of Drug Treatment], complete response rate, drug fatality/si [Side Effect], adult, age, aged, article, cancer combination chemotherapy, cancer patient, cancer prognosis, cancer radiotherapy, cancer regression, cancer survival, clinical article, clinical outcome, cohort analysis, consolidation chemotherapy, controlled study, drug dose reduction, drug megadose, female, human, immunocompetence, male, median survival time, multiple cycle treatment, neurotoxicity/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27443Test
Leukemia and Lymphoma
Click here for full text options
LibKey Link

مصطلحات الفهرس: observational study, oncological parameters, overall response rate, overall survival, primary central nervous system lymphoma/dt [Drug Therapy], primary central nervous system lymphoma/rt [Radiotherapy], priority journal, progression free survival, retrospective study, salvage therapy, survival analysis, survival rate, treatment outcome, treatment refusal, treatment response, whole brain radiotherapy, corticosteroid, cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/to [Drug Toxicity], cytarabine/pv [Special Situation for Pharmacovigilance], cytarabine/tm [Unexpected Outcome of Drug Treatment], methotrexate/ae [Adverse Drug Reaction], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], methotrexate/to [Drug Toxicity], methotrexate/tl [Intrathecal Drug Administration], methotrexate/pv [Special Situation for Pharmacovigilance], methotrexate/tm [Unexpected Outcome of Drug Treatment], procarbazine/ae [Adverse Drug Reaction], procarbazine/cb [Drug Combination], procarbazine/dt [Drug Therapy], procarbazine/to [Drug Toxicity], procarbazine/pv [Special Situation for Pharmacovigilance], procarbazine/tm [Unexpected Outcome of Drug Treatment], rituximab/ae [Adverse Drug Reaction], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], rituximab/to [Drug Toxicity], rituximab/pv [Special Situation for Pharmacovigilance], rituximab/tm [Unexpected Outcome of Drug Treatment], vincristine/ae [Adverse Drug Reaction], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], vincristine/to [Drug Toxicity], vincristine/pv [Special Situation for Pharmacovigilance], vincristine/tm [Unexpected Outcome of Drug Treatment], complete response rate, drug fatality/si [Side Effect], adult, age, aged, article, cancer combination chemotherapy, cancer patient, cancer prognosis, cancer radiotherapy, cancer regression, cancer survival, clinical article, clinical outcome, cohort analysis, consolidation chemotherapy, controlled study, drug dose reduction, drug megadose, female, human, immunocompetence, male, median survival time, multiple cycle treatment, neurotoxicity/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27443Test
Leukemia and Lymphoma
LibKey Link

مصطلحات الفهرس: rituximab/dt [Drug Therapy], vincristine/dt [Drug Therapy], vincristine sulfate/cb [Drug Combination], vincristine sulfate/cm [Drug Comparison], vincristine sulfate/dt [Drug Therapy], bcl2 gene, BCL6 gene, gene rearrangement, Herpes simplex virus, human, lymphoma, maintenance therapy, mantle cell lymphoma/dt [Drug Therapy], multiple myeloma/th [Therapy], myeloma/th [Therapy], New Zealand, oncogene myc, pandemic, patient attitude, priority journal, salvage therapy, screening test, telehealth, vaccination, virus shedding, virus transmission, cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], doxorubicin/cb [Drug Combination], doxorubicin/cm [Drug Comparison], doxorubicin/dt [Drug Therapy], etoposide/cb [Drug Combination], etoposide/dt [Drug Therapy], growth factor, ibrutinib/dt [Drug Therapy], ifosfamide/cb [Drug Combination], ifosfamide/dt [Drug Therapy], immunoglobulin, methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], Myc protein/ec [Endogenous Compound], prednisolone/cb [Drug Combination], prednisolone/cm [Drug Comparison], prednisolone/dt [Drug Therapy], prednisone/cb [Drug Combination], prednisone/cm [Drug Comparison], prednisone/dt [Drug Therapy], protein bcl 2/ec [Endogenous Compound], protein bcl 6/ec [Endogenous Compound], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], venetoclax/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/cm [Drug Comparison], AL amyloidosis, antifungal therapy, article, Australian, autologous stem cell transplantation, B cell lymphoma/dt [Drug Therapy], Burkitt lymphoma/dt [Drug Therapy], cancer grading, cancer immunotherapy, cancer radiotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], coronavirus disease 2019, diagnostic test, diffuse large B cell lymphoma/rt [Radiotherapy], follicular lymphoma/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29271Test
Internal Medicine Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: rituximab/dt [Drug Therapy], vincristine/dt [Drug Therapy], vincristine sulfate/cb [Drug Combination], vincristine sulfate/cm [Drug Comparison], vincristine sulfate/dt [Drug Therapy], bcl2 gene, BCL6 gene, gene rearrangement, Herpes simplex virus, human, lymphoma, maintenance therapy, mantle cell lymphoma/dt [Drug Therapy], multiple myeloma/th [Therapy], myeloma/th [Therapy], New Zealand, oncogene myc, pandemic, patient attitude, priority journal, salvage therapy, screening test, telehealth, vaccination, virus shedding, virus transmission, cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], doxorubicin/cb [Drug Combination], doxorubicin/cm [Drug Comparison], doxorubicin/dt [Drug Therapy], etoposide/cb [Drug Combination], etoposide/dt [Drug Therapy], growth factor, ibrutinib/dt [Drug Therapy], ifosfamide/cb [Drug Combination], ifosfamide/dt [Drug Therapy], immunoglobulin, methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], Myc protein/ec [Endogenous Compound], prednisolone/cb [Drug Combination], prednisolone/cm [Drug Comparison], prednisolone/dt [Drug Therapy], prednisone/cb [Drug Combination], prednisone/cm [Drug Comparison], prednisone/dt [Drug Therapy], protein bcl 2/ec [Endogenous Compound], protein bcl 6/ec [Endogenous Compound], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], venetoclax/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/cm [Drug Comparison], AL amyloidosis, antifungal therapy, article, Australian, autologous stem cell transplantation, B cell lymphoma/dt [Drug Therapy], Burkitt lymphoma/dt [Drug Therapy], cancer grading, cancer immunotherapy, cancer radiotherapy, cancer recurrence, chronic lymphatic leukemia/dt [Drug Therapy], coronavirus disease 2019, diagnostic test, diffuse large B cell lymphoma/rt [Radiotherapy], follicular lymphoma/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29271Test
Internal Medicine Journal
LibKey Link

مصطلحات الفهرس: priority journal, overall survival, neurologic disease, male, female, human, incidence, disease association, disease control, drug megadose, major clinical study, adult, aged, article, Australia, autologous stem cell transplantation, cancer radiotherapy, cancer survival, clinical feature, clinical outcome, cohort analysis, comparative study, controlled study, diffuse large B cell lymphoma/dt [Drug Therapy], progression free survival, relapse, retrospective study, treatment duration, treatment outcome, United Kingdom, cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine/dt [Drug Therapy], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/iv [Intravenous Drug Administration], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35962Test
British Journal of Haematology
Click here for full text options
LibKey Link

مصطلحات الفهرس: cohort analysis, controlled study, double blind procedure, drug efficacy, drug safety, drug tolerability, good clinical practice, health care policy, hospitalization, human, major clinical study, multicenter study, outcome assessment, randomized controlled trial, sensitivity analysis, single drug dose, uterine tube pregnancy/di [Diagnosis], uterine tube pregnancy/dt [Drug Therapy], gefitinib/ct [Clinical Trial], gefitinib/cb [Drug Combination], gefitinib/cm [Drug Comparison], gefitinib/dt [Drug Therapy], gefitinib/po [Oral Drug Administration], methotrexate/ct [Clinical Trial], methotrexate/cb [Drug Combination], methotrexate/cm [Drug Comparison], methotrexate/do [Drug Dose], methotrexate/dt [Drug Therapy], methotrexate/im [Intramuscular Drug Administration], placebo, adult, female, article, body mass, clinical protocol, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36975Test
Trials
Click here for full text options
LibKey Link

مصطلحات الفهرس: positron emission tomography, cancer prognosis, cancer recurrence, cancer staging, cancer survival, Chlamydia psittaci, computer assisted tomography, drug effect, drug targeting, event free survival, fluorescence in situ hybridization, Helicobacter pylori, Hepatitis C virus, human, mantle cell lymphoma/di [Diagnosis], mantle cell lymphoma/dt [Drug Therapy], marginal zone lymphoma/di [Diagnosis], marginal zone lymphoma/dt [Drug Therapy], multiple cycle treatment, nonhuman, overall survival, priority journal, progression free survival, review, survival time, treatment duration, treatment outcome, treatment planning, tumor biopsy, bendamustine/cb [Drug Combination], bendamustine/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], cytarabine/dt [Drug Therapy], doxorubicin/cb [Drug Combination], doxorubicin/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/dt [Drug Therapy], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], Australia, Borrelia burgdorferi, Campylobacter jejuni, cancer combination chemotherapy, cancer immunotherapy, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35992Test
Internal Medicine Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: priority journal, overall survival, neurologic disease, male, female, human, incidence, disease association, disease control, drug megadose, major clinical study, adult, aged, article, Australia, autologous stem cell transplantation, cancer radiotherapy, cancer survival, clinical feature, clinical outcome, cohort analysis, comparative study, controlled study, diffuse large B cell lymphoma/dt [Drug Therapy], progression free survival, relapse, retrospective study, treatment duration, treatment outcome, United Kingdom, cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine/dt [Drug Therapy], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], cytarabine/iv [Intravenous Drug Administration], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35962Test
British Journal of Haematology
LibKey Link

مصطلحات الفهرس: cohort analysis, controlled study, double blind procedure, drug efficacy, drug safety, drug tolerability, good clinical practice, health care policy, hospitalization, human, major clinical study, multicenter study, outcome assessment, randomized controlled trial, sensitivity analysis, single drug dose, uterine tube pregnancy/di [Diagnosis], uterine tube pregnancy/dt [Drug Therapy], gefitinib/ct [Clinical Trial], gefitinib/cb [Drug Combination], gefitinib/cm [Drug Comparison], gefitinib/dt [Drug Therapy], gefitinib/po [Oral Drug Administration], methotrexate/ct [Clinical Trial], methotrexate/cb [Drug Combination], methotrexate/cm [Drug Comparison], methotrexate/do [Drug Dose], methotrexate/dt [Drug Therapy], methotrexate/im [Intramuscular Drug Administration], placebo, adult, female, article, body mass, clinical protocol, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36975Test
Trials
LibKey Link

مصطلحات الفهرس: positron emission tomography, cancer prognosis, cancer recurrence, cancer staging, cancer survival, Chlamydia psittaci, computer assisted tomography, drug effect, drug targeting, event free survival, fluorescence in situ hybridization, Helicobacter pylori, Hepatitis C virus, human, mantle cell lymphoma/di [Diagnosis], mantle cell lymphoma/dt [Drug Therapy], marginal zone lymphoma/di [Diagnosis], marginal zone lymphoma/dt [Drug Therapy], multiple cycle treatment, nonhuman, overall survival, priority journal, progression free survival, review, survival time, treatment duration, treatment outcome, treatment planning, tumor biopsy, bendamustine/cb [Drug Combination], bendamustine/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], cytarabine/dt [Drug Therapy], doxorubicin/cb [Drug Combination], doxorubicin/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/dt [Drug Therapy], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], Australia, Borrelia burgdorferi, Campylobacter jejuni, cancer combination chemotherapy, cancer immunotherapy, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35992Test
Internal Medicine Journal
LibKey Link